Name: Assessing Urinary Tract Junction Obstruction Defects by Methylene Blue Dye Injection (Video) | JoVE Journal
Uploaded: 2017-10-12T12:30:00.000+00:00
Duration: 6 min 5 s
Description: Learn to assess urinary tract junction obstruction defects in mouse embryos using methylene blue dye injection. This method visualizes renal structures and identifies developmental anomalies in kidney research.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

I thank Dr. Alan O. Perantoni (CDBL/NCI/NIH) for supporting the submission of this manuscript. I also thank Dr. Michael Hall (CDBL/NCI/NIH) and Nirmala Sharma (CDBL/NCI/NIH) for editing this manuscript. I am grateful to Lai Thang (SAIC) for his excellent mouse husbandry. This work was supported by the National Institutes of Health, National Cancer Institute and Center for Cancer Research.

Mice (Wnt5a flox/flox mice (Wnt5atm1.1Tpy) and Dll1Cre line, UVJO mouse model)7 were managed according to NIH guidelines for the care and use of laboratory animals and studied under a protocol approved by the NCI-Frederick Animal Care and Use Committee.
1. Preparation of Methylene Blue Dye Solution
<ol>
	<li>Measure 0.1 g methylene blue powder.</li>
	<li>Dissolve the methylene blue in 10 mL normal saline or 1x phosphate buffered saline (PBS) completely by vortexing.</li>
	<li>Filter the 10 mg/mL methylene blue solution with a syringe filter (membrane pore size 0.45&#181;m) to eliminate clogging during injection.</li>
	<li>Assemble a sterile scalp vein set (27GX3/4&#8243;) with a 3 mL disposable syringe and fill the syringe with 3 mL filtered methylene blue solution. 
	NOTE: To prevent hydrostatic pressure and subsequent dye flow, place the needle tip above the syringe filled with methylene blue solution.</li>
</ol>
2. Dissection of Prenatal Embryos
<ol>
	<li>Clean dissecting scissors and forceps with 70% ethanol.</li>
	<li>To collect perinatal embryos at E18.5 or E19.5, euthanize pregnant mice first using CO2 inhalation and then perform cervical dislocation according to NIH guidelines. 
	NOTE: The pregnant female mouse usually gives birth starting at E18.5, however, larger kidneys are easier to manipulate. Therefore, kidneys at E19.5 closer to birth are easier to perform this analysis on. However, pups with bilateral urinary tract obstructions die after birth. Depending on the characteristics of experimental mice, an appropriate collection day/time should be empirically determined.</li>
	<li>Spray 70% ethanol on the ventral abdominal surface and then open the abdominal cavity ventrally using dissecting scissors and forceps.</li>
	<li>Lift the entire uterus and separate it from the body by cutting with dissecting scissors at the tips of the uterine horns.</li>
	<li>Rinse the entire uterus with 1x PBS in a petri dish.</li>
	<li>Cut the uterus segmentally with dissecting scissors and remove placental decidua with dissecting forceps to expose the embryos in yolk sacs.</li>
	<li>Remove the yolk sac first and then remove the amniotic membrane with dissecting forceps to liberate the perinatal embryos.</li>
	<li>Decapitate an embryo with dissecting scissors. Wipe off excess blood with sterile gauze pads. Pin the embryo down with its ventral surface up on a dissecting microscope equipped with a digital camera for imaging. Collect its tail for genotyping if necessary. 
	NOTE: Perform injections one embryo at a time.</li>
	<li>Carefully open the abdominal cavity of an embryo with forceps by tearing the skin. Then, carefully remove excess organs and tissues such as liver, stomach, and intestine with forceps by cutting them or pulling them out to expose the kidneys, the ureters, and the bladder that are located dorsally (Figure 1A). Absorb excess blood from the dissected embryo with sterile gauze pads if necessary. 
	NOTE: Excess blood interferes with identification of the renal pelvis for the dye injection.</li>
</ol>
3. Injection of Methylene Blue Dye into the Renal Pelvis and Monitoring Dye Flow
<ol>
	<li>Remove bubbles in the needle and tubing by expelling methylene blue solution from the needle tip by hydrostatic pressure. Lift the syringe containing the dye solution above the level of the needle tip to start flow, and then lower the syringe to stop flow.</li>
	<li>Insert the needle into the renal pelvis near the proximal ureter, taking care not to disturb it once placed. Perform dye injection into a kidney to determine its urinary tract obstruction. 
	NOTE: Perform dye injection into any abnormal kidney7 first by following the same way to determine its urinary tract obstruction.</li>
	<li>Lift the syringe up about 20 cm to provide hydrostatic pressure and let 15 &#181;L - 60 &#181;L of the dye solution flow. The flow rate will be about 3 &#181;L/s if the syringe is raised to this height above the embryo.</li>
	<li>Monitor the blue color of the dye starting first in the renal pelvis, then in the length of the ureter, and finally in the bladder lumen. 
	NOTE: It takes about 5 s to see a weak dye color emerge within the bladder lumen if the ureter is properly inserted into the bladder. Allow the dye to accumulate at the blocked site about 15 s if no dye color appears in the bladder lumen.</li>
	<li>Place the syringe down to stop dye flow and remove the needle from the kidney.</li>
	<li>Take images of the kidney, the ureter, and the bladder traced with dye solution using the camera and imaging program connected to a stereomicroscope.</li>
	<li>Make a record of hydronephrosis of the kidney, hydroureter, and the final position of the dye solution in a lab notebook.</li>
	<li>Perform injection of the contralateral kidney as described in sections 3.1) to 3.5) and allow dye flow about 20 s in total. 
	NOTE: The bladder lumen will be filled with dye solution, indicated by a strong blue color, if the ureter is properly inserted into the bladder lumen. After assessment of urinary tract junction obstruction, the ureters and the bladder can be fixed for sectioning.</li>
</ol>

<ol><li>Rasouly, H. M., Lu, W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Lower+urinary+tract+development+and+disease%5BTitle%5D)+AND+%22Wiley+Interdiscip+Rev+Syst+Biol+Med%22%5BJournal%5D)">Lower urinary tract development and disease.</a> Wiley Interdiscip Rev Syst Biol Med. 5, 307-342 (2013).</li>
<li>Kispert, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((T-Box+Genes+in+the+Kidney+and+Urinary+Tract%5BTitle%5D)+AND+%22Curr+Top+Dev+Biol%22%5BJournal%5D)">T-Box Genes in the Kidney and Urinary Tract.</a> Curr Top Dev Biol. 122, 245-278 (2017).</li>
<li>Bohnenpoll, T., Kispert, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Ureter+growth+and+differentiation%5BTitle%5D)+AND+%22Semin+Cell+Dev+Biol%22%5BJournal%5D)">Ureter growth and differentiation.</a> Semin Cell Dev Biol. 36, 21-30 (2014).</li>
<li>Nicolaou, N., Renkema, K. Y., Bongers, E. M., Giles, R. H., Knoers, N. V. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Genetic%2C+environmental%2C+and+epigenetic+factors+involved+in+CAKUT%5BTitle%5D)+AND+%22Nat+Rev+Nephrol%22%5BJournal%5D)">Genetic, environmental, and epigenetic factors involved in CAKUT.</a> Nat Rev Nephrol. 11, 720-731 (2015).</li>
<li>Tripathi, P., Wang, Y., Casey, A. M., Chen, F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Absence+of+canonical+Smad+signaling+in+ureteral+and+bladder+mesenchyme+causes+ureteropelvic+junction+obstruction%5BTitle%5D)+AND+%22J+Am+Soc+Nephrol%22%5BJournal%5D)">Absence of canonical Smad signaling in ureteral and bladder mesenchyme causes ureteropelvic junction obstruction.</a> J Am Soc Nephrol. 23, 618-628 (2012).</li>
<li>Aoki, Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Id2+haploinsufficiency+in+mice+leads+to+congenital+hydronephrosis+resembling+that+in+humans%5BTitle%5D)+AND+%22Genes+Cells%22%5BJournal%5D)">Id2 haploinsufficiency in mice leads to congenital hydronephrosis resembling that in humans.</a> Genes Cells. 9, 1287-1296 (2004).</li>
<li>Yun, K., Perantoni, A. O. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Hydronephrosis+in+the+Wnt5a-ablated+kidney+is+caused+by+an+abnormal+ureter-bladder+connection%5BTitle%5D)+AND+%22Differentiation%22%5BJournal%5D)">Hydronephrosis in the Wnt5a-ablated kidney is caused by an abnormal ureter-bladder connection.</a> Differentiation. 94, 1-7 (2017).</li>
<li>Uetani, N., Bouchard, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Plumbing+in+the+embryo%3A+developmental+defects+of+the+urinary+tracts%5BTitle%5D)+AND+%22Clin+Genet%22%5BJournal%5D)">Plumbing in the embryo: developmental defects of the urinary tracts.</a> Clin Genet. 75, 307-317 (2009).</li>
<li>Murawski, I. J., Watt, C. L., Gupta, I. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Assessing+urinary+tract+defects+in+mice%3A+methods+to+detect+the+presence+of+vesicoureteric+reflux+and+urinary+tract+obstruction%5BTitle%5D)+AND+%22Methods+Mol+Biol%22%5BJournal%5D)">Assessing urinary tract defects in mice: methods to detect the presence of vesicoureteric reflux and urinary tract obstruction.</a> Methods Mol Biol. 886, 351-362 (2012).</li>
<li>Weiss, A. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Nephric+duct+insertion+requires+EphA4%2FEphA7+signaling+from+the+pericloacal+mesenchyme%5BTitle%5D)+AND+%22Development%22%5BJournal%5D)">Nephric duct insertion requires EphA4/EphA7 signaling from the pericloacal mesenchyme.</a> Development. 141, 3420-3430 (2014).</li>
</ol>

The author has nothing to disclose.

Mouse kidneys are functional beginning at E16.5 and a dye injection test is theoretically possible from this time point. However, the kidney is too small to be injected with the dye solution and phenotypes such as hydronephrosis and hydroureter are not clearly observed since these phenotypes are a secondary effect of urine built up due to abnormal urine transport. These phenotypes, from the obstructions such as UPJO or UVJO, are evident at E18.5 by distended kidneys and ureters. Larger kidneys of embryos at E19.5 or neon...

The urinary system consists of a pair of kidneys and ureters and a common bladder and urethra. The main function of the urinary system is to maintain body homeostasis by managing the water and electrolyte balance of the blood. The kidneys filter the blood to control electrolyte concentrations and acid-base balance,and produce urine to excrete excess water and waste including solutes and metabolites. Urine is then transported through the ureter from the renal pelvis of the kidney to the bladderin a unidirectional manner where it is stored and ultimately eliminated via the urethra1.
The ureters are straight tubes originating from the nephric duct. After budding from the nephric duct at embryonic day 10.5 (E10.5) in the mouse, the ureter stalk elongates and differentiates into a multilayered structure called urothelium which is impermeable between mouse E12.5 and E16.5. The mesenchymal cells surrounding the ureter stalk are also differentiated into three layers consisting of inner stromal cells, intermediate thick smooth muscle cells, and outer adventitial fibroblasts. Ureteral peristaltic waves initiating in the renal pelvis are propagated through the smooth muscle layer of the ureter wall to the bladder to transport urine2,3, which is produced starting at E16.5 in the mouse1.
Congenital anomalies of the kidney and urinary tract (CAKUT) are among the most frequent genetic diseases, present in around 1% of human fetuses1,4, and composed of a variety of phenotypes including hydronephrosis and hydroureter. The abnormal accumulation of urine in the kidney and ureter results in hydronephrotic kidney and hydroureter formation. One cause of hydronephrosis and/or hydroureter formation is an obstruction of the urinary tract. Ureteropelvic junction obstruction (UPJO) is caused by aberrant urine flow due to a blockage between the proximal ureter and the renal pelvis, resulting in hydronephrosis and proximal hydroureter narrowing with angulation or persistent folding5,6. In addition, the ectopic insertion of the distal ureter into either the bladder wall or the reproductive tract is called ureterovesical junction obstruction (UVJO). UVJO can also induce hydronephrosis and hydromegaureter formation7,8. An additional ureterovesical junction (UVJ) defect is vesicoureteric reflux (VUR). VUR is characterized by retrograde urine flow from the bladder toward the kidney at UVJ. Compared to UVJO, perinatal embryos with VUR do not distinctly show a distended hydronephrotic kidney or severe hydroureter phenotype9.
In the laboratory mouse, urine flow can be examined by injection of a dye, such as methylene blue, into the renal pelvis9. The injectedmethylene blue solution will trace the urine trajectory from the renal pelvis through the ureter and into the bladder. Hydronephrosis can be recognized by an expansion of the dye in the kidney. UPJO can be detected as a blockage of dye flow at the proximal ureter with distended renal pelvis5. Any dilation of the ureter indicated by a widened diameter demonstrates an example of hydroureter. Finally, dye accumulation at the bladder wall or at the site of the reproductive tract indicates UVJO with distended hydronephrotic kidney and dilated hydromegaureter7,10. To detect VUR, the dye solution is injected into the bladder and subsequent retrograde flow is monitored in the kidney9.
Here, a protocol for methylene blue dye injection into the renal pelvis of a perinatal embryo is presented. This protocol allows the tracing of urine flow from the renal pelvis through the ureter and into the bladder and verifies potential urinary tract junction obstructions such as UPJO or UVJO.

<table><tbody><tr><td>Methylene blue</td><td>Sigma-Aldrich</td><td>M9140</td><td></td></tr><tr><td>Quality Biological Inc. NORMAL SALINE - 500ML</td><td>Fisherscientific</td><td>50-983-204</td><td></td></tr><tr><td>3 mL disposable syringe with BD Luer-Lok tip</td><td>BD</td><td>309657</td><td></td></tr><tr><td>Acrodisc Syringe Filters with Supor Membrane</td><td>Pall corporation</td><td>4614</td><td></td></tr><tr><td>Exel Scalp Vein (Butterfly) Sets; 27G x 3/4&quot; 12&quot;&amp;nbsp;</td><td>EXELINT</td><td>26709</td><td></td></tr><tr><td>Delicate Operating Scissors</td><td>Roboz Surgical Instrument Co.</td><td>RS-6702</td><td></td></tr><tr><td>Micro Dissecting Forceps</td><td>Roboz Surgical Instrument Co.</td><td>RS-5135</td><td></td></tr><tr><td>Dumont Tweezers; Pattern #5</td><td>Roboz Surgical Instrument Co.</td><td>RS-5045</td><td></td></tr><tr><td>BD PrecisionGlide Needles 30 G x 1/2&quot;</td><td>BD</td><td>305106</td><td></td></tr></tbody></table>

assessing urinary tract junction obstruction defects by methylene blue dye injection

Assessing Urinary Tract Junction Obstruction Defects by Methylene Blue Dye Injection

Urinary tract junction obstruction defects are congenital anomalies inducing hydronephrosis and hydroureter. Murine urinary tract junction obstruction defects can be assessed by tracking methylene blue dye flow within the urinary system. Methylene blue dye is injected into the renal pelvis of perinatal embryonic kidneys and dye flow is monitored from the renal pelvis of the kidney through the ureter and into the bladder lumen after applying hydrostatic pressure. Dye accumulation will be evident in the bladder lumen of the normal perinatal urinary tract, but will be constrained between the renal pelvis and the end point of an abnormal ureter, if urinary tract obstructions occur. This method facilitates the confirmation of urinary tract junction obstructions and visualization of hydronephrosis and hydroureter. This manuscript describes a protocol for methylene blue dye injection into the renal pelvis to confirm urinary tract junction obstructions.

The kidneys and lower urinary system are located dorsal to most other internal organs such as the liver and intestine. After removing these other internal organs, a pair of kidneys and ureters and a single bladder are visible (Figure 1A). Upon successful dissection, the dye injected into the renal pelvis will flow from the kidney into the bladder via the ureter. The renal pelvis is the funnel-like dilated proximal part of the ureter in the kidney. Therefore, ...

Methylene blue dye injection into the renal pelvis facilitates the assessment of urinary tract junction obstruction defects during mouse embryonic urinary tract development. Here, a protocol for methylene blue dye injection into the renal pelvis is described.

Urinary tract junction obstruction defects are congenital anomalies inducing hydronephrosis and hydroureter. Murine urinary tract junction obstruction ...

The overall goal of this procedure is to determine the obstructions of urinary tract junctions via methylene dye injection into kidneys. This method can help answer key questions in the kidney and lower urinary tract development field, such as uretal bladder connection. The main advantage of this technique is that it provides a simple method to visualize the urinary tract structure in worst case mass development enabling urinal tract development analysis.To begin the experiment measure 0.1 gram of methylene blue powder. Dissolve the methylene blue in 10 milliliters of 1x phosphate buffered saline or PBS and vortex the mixture. Next filter the 10 milligram per milliliter methylene blue solution with a syringe filter to eliminate clogging during injection.Then assemble a sterile scalp vein set with a three milliliter disposable syringe and fill the syringe with three milliliters of filtered methylene blue solution. Clean dissecting scissors and forceps with 70%ethanol. To collect perinatal embryos at E18.5 or E19.5 first euthanize pregnant mice using carbon dioxide inhalation.Then perform cervical dislocation according to NIH guidelines. Next spray 70%ethanol on the ventral abdominal surface of the animal. Then using the sterile dissecting scissors and forceps open the abdominal cavity ventrally.Lift the entire uterus and separate it from the body at the tips of the uterine horns. Then rinse the entire uterus with 1x PBS in a petri dish. Cut the uterus segmentally with dissecting scissors and remove the placental decidua with dissecting forceps to expose the embryos and yolk sacs.Remove the yolk sac first and then remove the amniotic membrane with dissecting forceps to liberate the perinatal embryos. Decapitate the embryo with dissecting scissors. Pin the embryo down with its ventral surface up on a dissecting microscope equipped with a digital camera for imaging.Collect its tail for genotyping. Using forceps carefully tear the skin to open the abdominal cavity of the embryo. Then carefully remove excess organs and tissues such as liver, stomach and intestines with forceps by cutting them or pulling them out to expose the kidneys, the ureters and the bladder that are located dorsally.Absorb excess blood from the dissected embryo with sterile gauze pads then continue to dye injection. Remove bubbles in the needle and tubing by expelling methylene blue solution from the needle tip by hydrostatic pressure. Lift the syring containing the dye solution above the level of the needle tip to start flow.And then lower the syringe to stop flow. Next insert the needle into the renal pelvis near the proximal ureter taking care not to disturb it once placed. Perform dye injection into a kidney to determine its urinary tract obstruction.After insertion of one needle into the renal pelvis the success of this test a needle should be inserted into the renal pelvis towards the ureter neither passing through the kidney nor towards the blood vessel. Lift the syringe up about 20 centimeters to provide hydrostatic pressure and let 15 to 16 microliters of the dye solution flow. Then monitor the blue color of the dye starting first in the renal pelvis then in the length of the ureter and finally in the bladder lumen.Place the syringe down to stop the dye flow and remove the needle from the kidney. Make a record of hydronephrosis of the kidney, hydroureter and the final position of the dye solution in a lab notebook. Finally perform injection of the contralateral kidney and allow the dye to flow for 20 seconds total.Take images of the kidney, the ureter and the bladder traced with dye solution using the camera and imaging program connected to a stereo microscope. After injection into one kidney the methylene blue dye flows from the renal pelvis through the ureter and into the bladder resulting in a visible blue color in the ureter and bladder lumen. A stronger blue appears in the bladder lumen due to a longer flow about 20 seconds after injection of both kidneys with dye indicating the absence of urinary tract junction obstruction in the second urinary system.When injecting an abnormally dilated hydroureter the final position of the dye solution is unclear. And ureterovesical junction obstruction or UVJO cannot be verified despite the absence of the dye in the bladder lumen because the abnormal hydroureter was damaged in the middle. While attempting this procedure it's important to remember to calculate the dye sac perinatal embryos to get intact urinary system.And remove bubbles not to block the dye flow.

assessing-urinary-tract-junction-obstruction-defects-methylene-blue

Research

JoVE Journal

Biology

Loss of peritoneal integrity provides a new paradigm to understand and treat chronic pelvic pain in women with mild forms of endometriosis and can be easily detected using intraoperative instillation of dye at the time of laparoscopy.

Intraoperative Detection of Subtle Endometriosis: A Novel Paradigm for Detection and Treatment of Pelvic Pain Associated with the Loss of Peritoneal Integrity

Probe-based confocal laser endomicroscopy enables real-time microscopy of the human urinary tract during cystoscopy, providing dynamic, intravital imaging of pathological states such as bladder cancer with cellular resolution.  Endomicroscopy may augment the diagnostic accuracy of standard white light endoscopy and provide intraoperative image guidance to improve surgical resection.

Probe-based Confocal Laser Endomicroscopy of the Urinary Tract: The Technique

In this video, we administer methylene blue dye injection into the urinary tract of a perinatal embryonic mouse to assess congenital anomalies related to urinary tract obstruction.

Methylene Blue Dye Injection in Mouse Embryonic Urinary Tract: A Method To Assess the Congenital Obstruction in the Urinary Tract

Photoacoustic cystography (PAC) has a great potential to map urinary bladders, a radiation sensitive internal organ in pediatric patients, without using any ionizing radiation or toxic contrast agent. Here we demonstrate the use of PAC for mapping urinary bladders with an injection of optical-opaque tracers in rats in vivo.

Photoacoustic Cystography

Transurethral instillation is a challenging procedure and has not been well described in the literature. The aim of this manuscript is to describe a technique for transurethral insertion of a catheter for intravesical delivery of liquids with active substances into the urinary bladder and/or prostate in adult male mice.

Transurethral Instillation Procedure in Adult Male Mouse

We describe the use of high frequency ultrasound with contrast imaging as a method to measure bladder volume, bladder wall thickness, urine velocity, void volume, void duration, and urethral diameter. This strategy can be used to assess voiding dysfunction and treatment efficacy in various mouse models of lower urinary tract dysfunction (LUTD).

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

This protocol describes the procedure for measuring ATP concentrations in the lumen of the bladder in an anesthetized rodent.

In Vivo Luminal Measurement of Distension-Evoked Urothelial ATP Release in Rodents

This protocol provides a guide for waterproofing the skin with cyanoacrylate to prevent urine absorption by fur and skin. It includes instructions for applying the glue to the skin, implanting a bladder catheter, and electrodes for cystometry and external urethral sphincter electromyography recordings in awake mice.

Optimizing Mouse Urodynamic Techniques for Improved Accuracy

The present protocol describes a step-by-step, reproducible model of unilateral ureteral obstruction.

An Immature Murine Model of Reversible Unilateral Ureteral Obstruction

Application of electrophysiology to accessible synapses provides a quantifiable measure of synaptic activity, useful in analyzing synaptic mutants.   This article describes a dissection method used to expose the neuromuscular junctions (NMJ) of Caenorhabditis elegans (C. elegans) and briefly discusses some of the uses to which this preparation can be applied.

Dissecting and Recording from The C. Elegans Neuromuscular Junction

Learn to assess urinary tract junction obstruction defects in mouse embryos using methylene blue dye injection. This method visualizes renal structures and identifies developmental anomalies in kidney research.

Assessing Urinary Tract Junction Obstruction Defects by Methylene Blue Dye Injection

Explore More Videos